Sandbox Reserved 350: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 7: Line 7:
<br />
<br />
Coagulation Factor V originally studied in 1987 by William H. Kane, Akitada Ichinose, Frederick S. Hagen and Earl W. Davie, out of University of Washington, Seattle. <ref name="Old">PMID: 2827731 </ref>
Coagulation Factor V originally studied in 1987 by William H. Kane, Akitada Ichinose, Frederick S. Hagen and Earl W. Davie, out of University of Washington, Seattle. <ref name="Old">PMID: 2827731 </ref>
[http://en.wikipedia.org/wiki/Coagulation_cascade Coagulation] is a complex cascade of a biological reaction that takes place after an injury causing bleeding, to prevent bleeding; A step of hemostatsis, which faccilitates the formation of fibrin.  There approiaxmetly 30 known factors which play a role in this massive cascade response.  A possible explannation for the sheer complexity associated with what is knwon about this cascade is that tight regulation for the formation of blood clots are crutial.
[http://en.wikipedia.org/wiki/Coagulation_cascade Coagulation] is a complex cascade of a biological reaction that takes place after an injury causing bleeding, to prevent bleeding; A step of hemostatsis, which facilitates the formation of fibrin.  There approximately 30 known factors which play a role in this massive cascade response.  A possible explanation for the sheer complexity associated with what is known about this cascade is that tight regulation for the formation of blood clots are crucial.
<br />
<br />
The role of Human Coagulation Factor V is to act as a cofactor along with Factor X and Prothrombin (Factor II, inactive) to form a [http://en.wikipedia.org/wiki/Prothrombinase Prothrombinase] complex activating Prothrobin to Thrombin (FIIa).  Thrombin is then able to activate Firinogen (Factor I) into Fibrin (FIa), which connects platelets bound at the site of injury; formation of a clot.
The role of Human Coagulation Factor V is to act as a cofactor along with Factor X and Prothrombin (Factor II, inactive) to form a [http://en.wikipedia.org/wiki/Prothrombinase Prothrombinase] complex activating Prothrobin to Thrombin (FIIa).  Thrombin is then able to activate Fibrinogen (Factor I) into Fibrin (FIa), which connects platelets bound at the site of injury; formation of a clot.
<br />
<br />
It is vital for controled blood clot formation based on known human diseases/conditions of irregular clotting which are quiet devastating.  Two clear aspects of blood clotting involves either under clotting or excessive clotting.  The inability to form a clot leads to excessive bleeding from a minor abration known as [http://en.wikipedia.org/wiki/Haemophilia hemophila]. <ref name="Hemo">PMID: 21453683 </ref> [http://en.wikipedia.org/wiki/Thrombosis Thrombosis] is the second case, where excessive clotting or clotting when no wound is present results in free floating embolisms or thombuses. <ref name="Throm">PMID: 21455860 </ref> Floating free in the blood allows the thrombus to lodge itself within the circulatory system, interferring with orgran downstream of the circulating blood.  Unusual blood circulation/clotting by a thrombus are causes of heart attacks, strokes and necrosis of tissue. <ref name="Throm2">PMID: 21359071 </ref>
It is vital for controlled blood clot formation based on known human diseases/conditions of irregular clotting which are quiet devastating.  Two clear aspects of blood clotting involve either under clotting or excessive clotting.  The inability to form a clot leads to excessive bleeding from a minor abration known as [http://en.wikipedia.org/wiki/Haemophilia hemophila]. <ref name="Hemo">PMID: 21453683 </ref> [http://en.wikipedia.org/wiki/Thrombosis Thrombosis] is the second case, where excessive clotting or clotting when no wound is present results in free floating embolisms or thombuses. <ref name="Throm">PMID: 21455860 </ref> Floating free in the blood allows the thrombus to lodge itself within the circulatory system, interferring with orgran downstream of the circulating blood.  Unusual blood circulation/clotting by a thrombus are causes of heart attacks, strokes and necrosis of tissue. <ref name="Throm2">PMID: 21359071 </ref>


{{STRUCTURE_1czv|PDB=1czv|SCENE=}}
{{STRUCTURE_1czv|PDB=1czv|SCENE=}}
Line 28: Line 28:
[[Image:3D Jellow B-Barrel Motif.png|thumb|left|upright=1.5|alt=Distorted Jelly-Roll β-barrel motif with three active loops. The β-barrel motif is labeled in red and the three loops in orange.|Secondary structure of C2 Domain of 1czv.]]
[[Image:3D Jellow B-Barrel Motif.png|thumb|left|upright=1.5|alt=Distorted Jelly-Roll β-barrel motif with three active loops. The β-barrel motif is labeled in red and the three loops in orange.|Secondary structure of C2 Domain of 1czv.]]
<br />
<br />
'''The FVa-C2''', which is classified as a ''' <font color='red'> distorted jelly-roll </font> ''' <scene name='Sandbox_Reserved_350/Expriment3/1'> β-barrel motif </scene>, is compossed of <scene name='Sandbox_Reserved_350/Expriment5/1'> eight major antiparallel strands  </scene> arranged into two ''' <font color='lawngreen'> β-sheets of five </font> and <font color='maroon'> three strands </font> ''' packed against one another.
'''The FVa-C2''', which is classified as a ''' <font color='red'> distorted jelly-roll </font> ''' <scene name='Sandbox_Reserved_350/Expriment3/1'> β-barrel motif </scene>, is composed of <scene name='Sandbox_Reserved_350/Expriment5/1'> eight major antiparallel strands  </scene> arranged into two ''' <font color='lawngreen'> β-sheets of five </font> and <font color='maroon'> three strands </font> ''' packed against one another.
<br />
<br />
Salt bridges located within the "upper" segment ''' <font color='goldenrod'> (Asp61-Arg134) </font>.  The C2-Domain of Human coagulation factor is homologous to a larger family of adhesion proteins; [http://proteopedia.org/wiki/index.php/Category:Discoidin_family Discoidin],but not related to synaptotagmin-like C2 domains.<ref name="Pubmed"/>
Salt bridges located within the "upper" segment ''' <font color='goldenrod'> (Asp61-Arg134) </font>.  The C2-Domain of Human coagulation factor is homologous to a larger family of adhesion proteins; [http://proteopedia.org/wiki/index.php/Category:Discoidin_family Discoidin], but not related to synaptotagmin-like C2 domains.<ref name="Pubmed"/>
<br />
<br />
<br />
<br />
Line 59: Line 59:
<br />
<br />


Functionality of Human Coagulation Factor V (FV), as most proteins is strongly correlated to the conformation of the overall strcture.  As noted above in the structural section, two structural forms of Human Coagulation Factor V C2 Domain were crystallized.  These two structures were disctinct from each other based on a conformational change present, alternating between what was described as a Open and Closed form.  This change from close to open by exposing this groove results due to the kind of environment Human Coagulation Factor V finds itself in, and ultimately the source of it's function.  This confers that FV is not an enzymatically active protein, but instead acts a cofactor part of the larger [http://en.wikipedia.org/wiki/File:Coagulation_full.svg Cougulation Cascade.]
Functionality of Human Coagulation Factor V (FV), as most proteins is strongly correlated to the conformation of the overall structure.  As noted above in the structural section, two structural forms of Human Coagulation Factor V C2 Domain were crystallized.  These two structures were distinct from each other based on a conformational change present, alternating between what was described as a Open and Closed form.  This change from close to open by exposing this groove results due to the kind of environment Human Coagulation Factor V finds itself in, and ultimately the source of its function.  This confers that FV is not an enzymatically active protein, but instead acts a cofactor part of the larger [http://en.wikipedia.org/wiki/File:Coagulation_full.svg Coagulation Cascade.]
<br />
<br />
The role of Human Coagulation Factor V, is act as a cofactor, enhances the ability of factor Xa to generate  from prothrombin once activated (Fva).  It is known that FV is activated in a positive feedback mechanism by α-thrombin and aided in conjunction with Human Coagulation Factor Xa, and inhibited by [http://en.wikipedia.org/wiki/Protein_C Active Protein C] [http://www.proteopedia.org/wiki/index.php/1aut (1aut)].
The role of Human Coagulation Factor V, is act as a cofactor, enhances the ability of factor Xa to generate  from prothrombin once activated (Fva).  It is known that FV is activated in a positive feedback mechanism by α-thrombin and aided in conjunction with Human Coagulation Factor Xa, and inhibited by [http://en.wikipedia.org/wiki/Protein_C Active Protein C] [http://www.proteopedia.org/wiki/index.php/1aut (1aut)].
Originally, the activation of FV to Fva was understood to require the exision of B segment between between the heavy and light chain at Arg-1018 and Arg-1545.  The peptide as a whole remains united via the disulfide linkage connecting the N and C Terminus and interactions with calcium ions. <ref name="Old"/>  In 1999, the [[#Finer Crystallography Details| crystalization]] of FV in both Fv and Fva was identified prodividing further insight into the quaternary structure of FV and the underlining mechanism by which the protein functions. <ref name="Pubmed"/>  This mechanism proposed has three novel points, which were over-looked based on assumed knowledge from previous studies modeling the mechanism for FV after the well characterized mechanism of vitamin K-dependent [http://en.wikipedia.org/wiki/Coagulation Coagulation Factors]; [http://en.wikipedia.org/wiki/Factor_VII VII] [http://proteopedia.org/wiki/index.php/1dan (1dan)]
Originally, the activation of FV to Fva was understood to require the excision of B segment between the heavy and light chain at Arg-1018 and Arg-1545.  The peptide as a whole remains united via the disulfide linkage connecting the N and C Terminus and interactions with calcium ions. <ref name="Old"/>  In 1999, the [[#Finer Crystallography Details| crystallization]] of FV in both Fv and Fva was identified providing further insight into the quaternary structure of FV and the underlining mechanism by which the protein functions. <ref name="Pubmed"/>  This mechanism proposed has three novel points, which were over-looked based on assumed knowledge from previous studies modeling the mechanism for FV after the well characterized mechanism of vitamin K-dependent [http://en.wikipedia.org/wiki/Coagulation Coagulation Factors]; [http://en.wikipedia.org/wiki/Factor_VII VII] [http://proteopedia.org/wiki/index.php/1dan (1dan)]
, [http://en.wikipedia.org/wiki/Factor_IX IX] [http://proteopedia.org/wiki/index.php/1pfx (1pfx)]
, [http://en.wikipedia.org/wiki/Factor_IX IX] [http://proteopedia.org/wiki/index.php/1pfx (1pfx)]
, [http://en.wikipedia.org/wiki/Factor_X X] [http://proteopedia.org/wiki/index.php/1c5m (1c5m)]
, [http://en.wikipedia.org/wiki/Factor_X X] [http://proteopedia.org/wiki/index.php/1c5m (1c5m)]